title: Persistent babesiosis in a stem cell transplant recipient.
authors.forename: Andrew S
authors.initials: AS
authors.lastname: Lubin
authors.forename: David R
authors.initials: DR
authors.lastname: Snydman
authors.forename: Kenneth B
authors.initials: KB
authors.lastname: Miller
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D053626:Atovaquone / Q000627:therapeutic use; D017963:Azithromycin / Q000627:therapeutic use; D001403:Babesia / Q000187:drug effects* / Q000302:isolation & purification; D001404:Babesiosis / Q000188:drug therapy* / Q000469:parasitology; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006801:Humans; D016867:Immunocompromised Host; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000601:surgery; D008297:Male; D008875:Middle Aged; D018512:Parasitemia / Q000188:drug therapy / Q000469:parasitology; D033581:Stem Cell Transplantation
chemical_list: D000900:Anti-Bacterial Agents; D000962:Antimalarials; D017963:Azithromycin; D053626:Atovaquone